Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 130,014 | 22,854 | 2,222 | 1,089 | 1,849 |
| Gross Profit | 130,014 | 22,854 | 2,222 | 1,089 | 1,849 |
| Operating Expenses | 128,546 | 123,220 | 104,593 | 109,504 | 115,944 |
| Operating Income | 1,468 | -100,366 | -102,371 | -108,415 | -114,095 |
| Interest Expense | 6,722 | 2,253 | 1,971 | 2,114 | 2,528 |
| Other Income | 572 | 2,255 | 216 | 318 | 408 |
| Pre-tax Income | -4,682 | -100,364 | -104,126 | -110,211 | -116,215 |
| Net Income Continuous | -4,682 | -100,364 | -104,126 | -110,211 | -116,215 |
| Net Income | $-4,682 | $-100,364 | $-104,126 | $-110,211 | $-116,215 |
| EPS Basic Total Ops | -0.05 | -1.31 | -1.42 | -1.61 | -2.38 |
| EPS Basic Continuous Ops | -0.05 | -1.31 | -1.42 | -1.57 | -2.39 |
| EPS Diluted Total Ops | -0.05 | -1.31 | -1.42 | -1.61 | -2.38 |
| EPS Diluted Continuous Ops | -0.05 | -1.31 | -1.42 | -1.57 | -2.39 |
| EBITDA(a) | $2,715 | $-98,338 | $-99,508 | $-104,225 | $-109,208 |